Hohimer Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Sell |
117,883
-42,759
| -27% | -$922K | 0.45% | 72 |
|
|
2025
Q1 | $2.67M | Sell |
160,642
-913
| -0.6% | -$15.2K | 0.52% | 68 |
|
|
2024
Q4 | $2.96M | Buy |
161,555
+2,422
| +2% | +$44.4K | 0.56% | 65 |
|
|
2024
Q3 | $2.45M | Hold |
159,133
| – | – | 0.53% | 78 |
|
|
2024
Q2 | $2.59M | Buy |
159,133
+142,000
| +829% | +$2.31M | 0.6% | 71 |
|
|
2024
Q1 | $317K | Hold |
17,133
| – | – | 0.07% | 197 |
|
|
2023
Q4 | $536K | Hold |
17,133
| – | – | 0.14% | 150 |
|
|
2023
Q3 | $357K | Sell |
17,133
-750
| -4% | -$15.6K | 0.1% | 160 |
|
|
2023
Q2 | $428K | Sell |
17,883
-2,382
| -12% | -$57K | 0.12% | 153 |
|
|
2023
Q1 | $381K | Hold |
20,265
| – | – | 0.11% | 157 |
|
|
2022
Q4 | $323K | Buy |
20,265
+4,250
| +27% | +$67.7K | 0.1% | 135 |
|
|
2022
Q3 | $262K | Sell |
16,015
-500
| -3% | -$8.18K | 0.08% | 153 |
|
|
2022
Q2 | $233K | Hold |
16,515
| – | – | 0.07% | 166 |
|
|
2022
Q1 | $400K | Hold |
16,515
| – | – | 0.08% | 156 |
|
|
2021
Q4 | $385K | Hold |
16,515
| – | – | 0.08% | 153 |
|
|
2021
Q3 | $274K | Buy |
16,515
+1,980
| +14% | +$32.9K | 0.06% | 157 |
|
|
2021
Q2 | $355K | Buy |
+14,535
| New | +$355K | 0.07% | 155 |
|
|
2021
Q1 | – | Sell |
-3,865
| Closed | -$207K | – | 193 |
|
|
2020
Q4 | $207K | Buy |
+3,865
| New | +$207K | 0.05% | 173 |
|
|
2020
Q3 | – | Sell |
-6,365
| Closed | -$309K | – | 181 |
|
|
2020
Q2 | $309K | Buy |
6,365
+2,500
| +65% | +$121K | 0.11% | 161 |
|
|
2020
Q1 | $201K | Sell |
3,865
-9,000
| -70% | -$468K | 0.08% | 170 |
|
|
2019
Q4 | $550K | Buy |
+12,865
| New | +$550K | 0.19% | 162 |
|